Serum HLA-A and B alloantigens in patients with malignant melanoma.
D003429:Cross Reactions; D003602:Cytotoxicity, Immunologic; D005260:Female; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics / Q000276:immunology*; D009367:Neoplasm Staging
D006680:HLA Antigens